Ozzi vs Lemme GLP-1 Daily: Honest 2026 Comparison
Ozzi and Lemme GLP-1 Daily both aim to support your body's natural GLP-1 production, but they take very different paths. Lemme uses 3 plant extracts in a 2-capsule daily dose. Ozzi uses 7 active ingredients including direct butyrate in a drink stick mixed with water once a day.
Key takeaways
- Lemme is 3 ingredients in capsules; Ozzi is 7 actives in a drink stick.
- Ozzi delivers direct butyrate, the SCFA most tied to L-cell GLP-1 release.
- Lemme costs $72 to $90 per month; Ozzi runs around $59 on subscription.
- Lemme is facing 2 class-action lawsuits over its GLP-1 weight-loss claims.
- Ozzi offers a 10-day feel-the-difference guarantee on your first bag.
What is Lemme GLP-1 Daily, exactly?
Lemme GLP-1 Daily is a capsule supplement from Lemme, the wellness brand founded by Kourtney Kardashian Barker. It launched in September 2024 and quickly became one of the most talked-about natural GLP-1 products on the market.
The formula contains 3 patented ingredients: Eriomin (a lemon fruit extract standardized for citrus flavonoids), Supresa (a saffron extract), and Morosil (a red orange extract rich in anthocyanins). The dose is 2 capsules per day with food.
Lemme retails for $72 per month on subscription, or $90 as a one-time purchase. That works out to about $2.40 to $3.00 per day.
The marketing positions Lemme as a way to "boost your body's natural GLP-1 by up to 17%." That number comes from a clinical study on the Eriomin ingredient alone, not the finished Lemme product.
What is Ozzi Crave Crusher?
Ozzi Crave Crusher is a drink stick you mix into 16 ounces of cold water. The stick weighs about 13 grams and contains 7 active ingredients targeting the same biology Lemme is going after, just from more angles.
The core stack is allulose (8.35g), glucomannan (0.556g), L-Lysine Butyrate as BIOMEnd (0.537g), chicory root inulin (0.5g), highly branched cyclic dextrin (0.5g), African mango extract (0.15g), and chromium polyursolate as Metabolex (11mg).
You drink one stick per day, usually in the morning or before your biggest meal. It tastes like watermelon. Subscription pricing lands at $59 per bag of 20 sticks, which is roughly $2.00 per day.
For background on what GLP-1 actually is and why it matters for cravings, see our pillar piece on what GLP-1 is and how it works.
How do the ingredients compare side by side?
This is the part most reviews skip. They list Lemme's 3 ingredients, list Ozzi's, and call it a day. The mechanisms are actually pretty different.
Lemme's approach is polyphenol-driven. The Eriomin flavonoids appear to act on gut microbiota composition, which then influences GLP-1 production indirectly. Saffron works centrally on serotonin signaling to reduce snacking urges. Morosil is mostly a fat-metabolism play through anthocyanin signaling.
Ozzi's approach is more mechanical. Butyrate from BIOMEnd binds to GPR41 and GPR43 receptors on intestinal L-cells, which directly triggers GLP-1 vesicle release. Inulin feeds the gut bacteria that produce more butyrate naturally. Glucomannan physically expands in your stomach. Allulose triggers GLP-1 through luminal distension.
| Feature | Lemme GLP-1 Daily | Ozzi Crave Crusher |
|---|---|---|
| Format | Capsule (2/day) | Drink stick (1/day) |
| Active ingredients | 3 | 7 |
| Direct GLP-1 trigger | No (flavonoid signaling) | Yes (butyrate + allulose) |
| Stomach fullness | No | Yes (glucomannan) |
| Prebiotic fiber | No | Yes (inulin) |
| Blood sugar support | Indirect | 4 mechanisms (allulose, glucomannan, inulin, chromium) |
| Sugar / sweetness | N/A | 0g sugar (allulose + Reb M) |
| Caffeine / stimulants | None | None |
| Cost per day (subscription) | ~$2.40 | ~$2.00 |
| Guarantee | Standard return policy | 10-day feel-the-difference on first bag |
Three ingredients versus seven isn't the whole story. It's the mechanisms behind them that decide whether anything actually changes.
Which one targets nighttime cravings better?
Nighttime cravings show up in almost half of our post-purchase surveys. People eat clean all day, then 9pm hits and the snacking starts. So this question matters.
Lemme's saffron extract has clinical data showing a 69% decrease in hunger and a 55% decrease in snacking events over 8 weeks at the dose used in Supresa's study. That's a real result, mediated through serotonin pathways. The catch is the effect builds over weeks, not in a single sitting.
Ozzi attacks cravings 3 different ways in one drink. Glucomannan expands in the stomach within about 30 minutes, creating physical fullness. Allulose hits sweet receptors without spiking blood sugar, so the "I want something sweet" loop quiets down. Direct butyrate plus the inulin-fed natural butyrate production pushes GLP-1, which is the satiety hormone GLP-1 agonist drugs mimic.
For more on this specific problem, our guide on the best supplements to curb sugar cravings goes deeper on the food noise mechanism.
What does the clinical evidence actually show?
Both brands rely on ingredient-level studies, not full-formula trials. That's standard in the supplement industry, but it matters to understand what each claim is actually built on.
For Lemme, the headline "17% GLP-1 increase" comes from a single human clinical study on Eriomin lemon extract. The study measured GLP-1 levels in blood after 12 weeks of supplementation. That's a real signal, but it doesn't translate automatically into weight loss or appetite suppression for everyone.
That gap is exactly what the 2 active class-action lawsuits against Lemme are targeting. Filed in February and March 2025, the complaints argue that even a 17% GLP-1 bump is small relative to natural daily fluctuations and may not produce meaningful clinical outcomes. The cases are still pending.
For Ozzi, the evidence base is broader but also fragmented across ingredients. Butyrate's role in stimulating GLP-1 release from intestinal L-cells is well established in cell and animal studies, with the mechanism mapped through GPR41/GPR43 receptor binding and HDAC inhibition. Allulose has multiple human trials showing postprandial GLP-1 increases and blood glucose attenuation. Glucomannan has a 2024 meta-analysis showing 3.18 kg average weight reduction at doses above 5g per day over 12 weeks (Ozzi uses 0.556g, which is lower).
Neither brand has run a full RCT on the finished product. Both are stacking ingredient-level evidence. The honest read is that Ozzi has more total evidence across more mechanisms, while Lemme has tighter evidence on fewer ingredients.
How does price per day compare?
Both products land in the same general range for a daily wellness habit, but the math differs.
Lemme costs $72 per month on subscription (60 capsules, 30 days at 2 caps daily), which is $2.40 per day. One-time purchase is $90, or $3.00 per day. There's no first-bag guarantee beyond standard return policy.
Ozzi costs about $59 per bag of 20 sticks on subscription, which is around $2.95 per stick if you take one a day. Most customers actually take it 5 to 6 days per week, which stretches a bag to roughly 24 days, bringing the per-day cost closer to $2.00. First bag is backed by a 10-day feel-the-difference guarantee. Use it 10 days in a row, and if you don't notice a difference, the first bag is refunded.
Which format works better, capsules or drink sticks?
This is mostly preference, but there are real functional differences worth knowing.
Capsules win on convenience. You can carry them anywhere, take them with any liquid, and the act of swallowing 2 pills takes 5 seconds. If you're already a "vitamin routine" person, adding 2 more capsules is friction-free.
Drink sticks deliver bulk ingredients that capsules physically cannot. Glucomannan needs 500mg or more to expand meaningfully in the stomach, which is hard to fit in a capsule footprint without taking 5 or 6 pills. Allulose at 8.35g per serving is impossible in capsule form. The drink also adds 16oz of water to your stomach, which helps with the fullness signal on its own.
If your goal is "support GLP-1 quietly in the background," capsules are fine. If your goal is "feel different at the next meal," the drink format does more.
Capsules can't physically deliver 8 grams of allulose or half a gram of fiber that expands in your stomach. That's just biology.
Who should pick Lemme, and who should pick Ozzi?
Honest answer: there's no universal "better." There are people who'll be happier with one or the other based on what they're optimizing for.
Pick Lemme if: You strongly prefer capsules over drinks, you're already a Lemme brand fan, you're drawn to saffron's serotonin-mediated effects on snacking, or you only have room in your routine for a tiny pill habit.
Pick Ozzi if: You want direct butyrate plus prebiotic fuel for natural butyrate production, you want bulk ingredients (allulose, glucomannan) that need a drink format to work, you struggle specifically with nighttime cravings and want fast-acting stomach fullness, or you want a 10-day money-back safety net on your first try.
For people coming off Ozempic or Wegovy and dealing with rebound hunger, our deeper piece on natural alternatives to Ozempic covers both products in that specific context. If you want a wider field comparison, see our best natural GLP-1 supplements for appetite control in 2026.
What about the Lemme class-action lawsuits?
Two class-action lawsuits were filed against Lemme Inc. in early 2025, both titled Robins v. Lemme Inc. One was filed February 19 in California, the other March 9 in the Southern District of New York. The NY case was dismissed from federal court and refiled in California.
The complaints don't argue Lemme is dangerous. They argue the GLP-1 weight-loss claims aren't backed by clinical data on the finished product, and that a 17% GLP-1 bump (the Eriomin headline number) is small relative to natural daily fluctuations.
This isn't a verdict. The cases are pending. But it does shape how you read the marketing. The same critique could be leveled at most GLP-1 supplements that lean on single-ingredient studies for product-level claims, Ozzi included. We're transparent about that. Our claims are about the ingredients and the mechanisms, not promises of pounds dropped.
Can you take Lemme and Ozzi together?
Probably, but we'd talk to your doctor first if you're on any medications.
The ingredients don't have any known dangerous interactions with each other. Saffron, citrus flavonoids, and red orange extract aren't going to fight with butyrate, allulose, or glucomannan in any way that's been documented.
But stacking them is also expensive ($4.40 to $5.40 per day combined) and you may not need both. Most people who try both end up picking one based on which they feel more from. Run them solo for a couple weeks each before deciding.
Frequently asked questions
Is Lemme GLP-1 Daily FDA-approved?
No. Lemme is a dietary supplement, not a drug. The FDA doesn't approve supplements before they're sold. The same applies to Ozzi.
How fast does each one work?
Lemme's saffron and Eriomin effects build over 4 to 12 weeks of daily use. Ozzi's glucomannan and allulose effects can show up in the first day or two through stomach fullness; the butyrate-GLP-1 mechanism takes longer to compound.
Is Ozzi vegan? Is Lemme vegan?
Ozzi is vegan-friendly. Lemme GLP-1 Daily uses vegetable cellulose capsules and is also labeled vegan.
Does either contain caffeine or stimulants?
Neither. Both are stimulant-free. This matters for people with anxiety, heart conditions, or who take them in the evening.
Will Ozzi or Lemme show up on a drug test?
No. Neither contains anything that would trigger a standard workplace or athletic drug test.
Are there side effects?
Lemme's most-reported issue in user reviews is mild GI upset. Ozzi can cause some gas or bloating in the first week as your gut adjusts to the inulin and butyrate, then it usually settles. Drinking enough water with Ozzi is important because glucomannan needs water to expand safely.
Can I take either one while on a real GLP-1 like Ozempic?
Talk to your doctor. Most prescribers we've heard from don't see a conflict with these ingredients, but they want to know about anything you're taking.
Does Ozzi really have a money-back guarantee?
Yes, on the first bag only. Use it for 10 days in a row. If you don't feel a difference, we refund your first bag. Lemme has a standard return policy with timeline-based eligibility but no specific "use it and see" structure.
What's the catch with celebrity supplement brands?
Celebrity brands often have great marketing budgets and weaker formulations. That's a generalization, not a Lemme-specific dig. The Lemme formula has real ingredients with real studies. The question is whether the product-level claims match what the ingredient evidence actually supports.
Try Ozzi risk-free for 10 days
One stick a day in 16oz of cold water. If you don't feel a difference in 10 days of consistent use, we refund your first bag. No reorder traps, no awkward phone calls.
References
- Yadav H, Lee JH, Lloyd J, et al. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem. 2013;288(35):25088-25097. https://pubmed.ncbi.nlm.nih.gov/23836895/
- Mizuma S, Hayakawa M, Hira T. Intestinal Distension Induced by Luminal D-allulose Promotes GLP-1 Secretion in Male Rats. Endocrinology. 2025;166(2):bqaf002. https://pubmed.ncbi.nlm.nih.gov/39821080/
- Noronha JC, Braunstein CR, Glenn AJ, et al. Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis. PLoS One. 2023;18(2):e0281150. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281150
- Mohammadpour S, et al. Effects of glucomannan supplementation on weight loss in overweight and obese adults: A systematic review and meta-analysis of randomized controlled trials. Obes Med. 2020;19:100276. https://www.sciencedirect.com/science/article/abs/pii/S2451847620300968
- Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2014;33(1):70-78. https://pubmed.ncbi.nlm.nih.gov/24533610/
- Franco RR, Justino AB, Martins MM, et al. Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. mBio. 2024;15(2):e02032-23. https://journals.asm.org/doi/10.1128/mbio.02032-23
- Ngondi JL, Etoundi BC, Nyangono CB, et al. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters. Lipids Health Dis. 2009;8:7. https://pubmed.ncbi.nlm.nih.gov/19254366/
- Cersosimo E, Triplitt C, Solis-Herrera C, et al. Pathogenesis of type 2 diabetes mellitus and the role of chromium. Endotext. 2018. https://www.ncbi.nlm.nih.gov/books/NBK279155/
- Cassidy YM, McSorley EM, Allsopp PJ. Effect of soluble dietary fibre on postprandial blood glucose response and its potential as a functional food ingredient. J Funct Foods. 2018;46:423-439. https://www.sciencedirect.com/science/article/abs/pii/S1756464618302378
- Robins v. Lemme Inc., No. 1:25-cv-01938 (S.D.N.Y. Mar. 9, 2025). Class action complaint regarding GLP-1 Daily supplement marketing. https://www.classaction.org/media/robins-v-lemme-inc.pdf